Target Name: MIR5703
NCBI ID: G100847081
Other Name(s): MicroRNA 5703 | hsa-mir-5703 | mir-5703 | hsa-miR-5703 | microRNA 5703

MIR5703: A Potential Drug Target and Biomarker

MIR5703 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its primary function is to regulate the blood flow to these organs, which is crucial for maintaining their health and function. MIR5703 has also been shown to play a key role in the development and progression of various diseases, including cancer.

Recent studies have identified MIR5703 as a potential drug target and biomarker for a variety of diseases, including cancer. MIR5703 has been shown to be highly expressed in various types of cancer, including breast, ovarian, and prostate cancer. Additionally, MIR5703 has been shown to play a role in the regulation of angiogenesis, which is the process by which new blood vessels grow in response to cancer.

One of the key advantages of MIR5703 as a drug target is its ability to be easily modified and inhibited. Researchers have identified several potential sites on MIR5703 that could be targeted with small molecules or antibodies. These sites include the N-terminus, the catalytic center, and the C-terminus.

In addition to its potential as a drug target, MIR5703 has also been shown to be a potential biomarker for a variety of diseases. The expression of MIR5703 has been shown to be associated with the development and progression of various diseases, including cancer. For example, studies have shown that MIR5703 is highly expressed in breast cancer tissue and that inhibiting MIR5703 has been shown to be effective in inhibiting the growth of breast cancer cells.

MIR5703 has also been shown to be expressed in various other types of cancer, including ovarian and prostate cancer. The expression of MIR5703 has been shown to be associated with the poor prognosis of these cancers, as well as the development of brain metastases.

In addition to its potential as a drug target and biomarker, MIR5703 has also been shown to play a key role in the regulation of angiogenesis. Angiogenesis is the process by which new blood vessels grow in response to cancer, and MIR5703 has been shown to play a role in regulating the formation of these blood vessels.

Overall, MIR5703 is a protein that has the potential to be a drug target and biomarker for a variety of diseases. Its ability to be easily modified and inhibited, as well as its association with the development and progression of various diseases, make it an attractive target for research and development. Further studies are needed to fully understand the role of MIR5703 in these processes and to determine its safety and efficacy as a potential drug.

Protein Name: MicroRNA 5703

More Common Targets

MIR5704 | MIR5705 | MIR5706 | MIR5707 | MIR5708 | MIR570HG | MIR571 | MIR572 | MIR573 | MIR5739 | MIR574 | MIR575 | MIR576 | MIR577 | MIR578 | MIR5787 | MIR579 | MIR580 | MIR581 | MIR582 | MIR583 | MIR584 | MIR585 | MIR586 | MIR587 | MIR588 | MIR589 | MIR590 | MIR591 | MIR592 | MIR593 | MIR595 | MIR596 | MIR597 | MIR598 | MIR599 | MIR600 | MIR600HG | MIR601 | MIR602 | MIR603 | MIR604 | MIR605 | MIR606 | MIR6068 | MIR6069 | MIR607 | MIR6070 | MIR6071 | MIR6072 | MIR6073 | MIR6074 | MIR6075 | MIR6076 | MIR6077 | MIR6078 | MIR608 | MIR6080 | MIR6081 | MIR6082 | MIR6083 | MIR6084 | MIR6085 | MIR6086 | MIR6088 | MIR6089 | MIR609 | MIR6090 | MIR610 | MIR611 | MIR612 | MIR6124 | MIR6125 | MIR6126 | MIR6127 | MIR6128 | MIR6129 | MIR613 | MIR6130 | MIR6131 | MIR6132 | MIR6133 | MIR6134 | MIR614 | MIR615 | MIR616 | MIR6165 | MIR617 | MIR618 | MIR619 | MIR620 | MIR621 | MIR622 | MIR623 | MIR624 | MIR625 | MIR626 | MIR627 | MIR628 | MIR629